Clinical Trial Update: Comparison of Two Insulin Degludec Formulations in Subjects With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing two insulin degludec formulations in adults with type 2 diabetes mellitus, with results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Tresiba (insulin degludec) U-100 (insulin degludec)
• Tresiba (insulin degludec) U-200 (insulin degludec)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Diabetes, Diabetes Mellitus, Type 2 | Phase 3 | Status: COMPLETED | Results posted: 2015-11-18